Solid lipid nanoparticles in cervical cancer: a comprehensive review of a decade of progress and prospects - Pharma Excipients
Summary by Pharma Excipients
1 Articles
1 Articles
Solid lipid nanoparticles in cervical cancer: a comprehensive review of a decade of progress and prospects - Pharma Excipients
Abstract Background: Cervical cancer is the second most commonly diagnosed cancer worldwide and the third leading cause of death among women, with approximately 604 127 new cases being reported in 2020. Conventional treatment methods, such as chemotherapy, radiation therapy, surgery, and hormonal therapy, often face significant challenges, including systemic toxicity and reduced efficacy, particularly in the advanced stages of the disease. The t…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium